The market of probiotics

Pakistan Journal of Pharmaceutical Sciences

Volumn 28, Issue 6, 2015, Pages 2199-2206

  Di Cerbo, Alessandro ^a   Palmieri, Beniamino ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Clinical nutrition; Health; Market; Probiotic

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; MINERAL; NUTRACEUTICAL; VITAMIN; YOGHURT;

DRUG MARKETING; HUMAN; NONHUMAN; REVIEW; ADVERTISING; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; ARTHRITIS; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CONSUMER; DAIRY PRODUCT; FERMENTED MILK PRODUCT; FUNCTIONAL FOOD; HYPERCHOLESTEROLEMIA; OBESITY; OSTEOPOROSIS; RISK REDUCTION; SPORTS DRINK;

ADVERTISING AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MARKETING OF HEALTH SERVICES; PROBIOTICS;

EID: 84947911932     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Amaretti A, Di Nunzio M, Pompei A, Raimondi S, Rossi M and Bordoni A (2013). Antioxidant properties of potentially probiotic bacteria: In vitro and in vivo activities. Appl. Microbiol. Biotechnol., 97: 809-817.
2. Anonymous (2012). Microbial products: Technologies, Applications and global markets BIO086A. BCC Research. Wellesley, MA, USA 1-165.
3. Anonymous (2013). The probiotics market: Ingredients, Supplements, Foods FOD035C [Online]. BCC Research. Available: http://www.bccresearch.com/ market-research/food-and-beverage/probiotics-marketingredients-foods-fod035c.html.
4. Asahara T, Shimizu K, Takada T, Kado S, Yuki N, Morotomi M, Tanaka R and Nomoto K (2011). Protective effect of lactobacillus casei strain shirota against lethal infection with multi-drug resistant Salmonella enterica serovar typhimurium DT104 in mice. J. Appl. Microbiol., 110: 163-73.
5. Aso Y and Akazan H (1992). Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol. Int., 49: 125-129.
6. Balaji Rr and Kantha Da (2011). Market potential for probiotic nutritional supplements in India. Afr. J. Bus. Manag., 5: 5418-5423.
7. Baldwin C, Millette M, Oth D, Ruiz Mt, Luquet Fm and Lacroix M (2010). Probiotic lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutr. Cancer, 62: 371-378.
8. Bertkova I, Hijova E, Chmelarova A, Mojzisova G, Petrasova D, Strojny L, Bomba A and Zitnan R (2010). The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma., 57: 422-428.
9. Besselink MG, Van Santvoort HC, Buskens E, Boermeester MA, Van Goor H, Timmerman Hm, Nieuwenhuijs VB, Bollen TL, Van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink Ma, Schaapherder Af, Dejong Ch, Wahab Pj, Van Laarhoven CJ, Van Der Harst E, Van Eijck CH, Cuesta Ma, Akkermans LM and Gooszen HG (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised. Lancet, 371: 651-659.
10. Bhadoria Pbs and Mahapatra Sc (2013). Prospects, technological aspects and limitations of probiotics a worldwide review. Eur. J. Food Res. Rev., 1: 23-42.
11. Borowicki A, Michelmann A, Stein K, Scharlau D, Scheu K, Obst U and Glei M (2011). Fermented wheat aleurone enriched with probiotic strains LGG and Bb12 modulates markers of tumor progression in human colon cells. Nutr. Cancer, 63: 151-160.
12. Borriello Sp, Hammes Wp, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M and Valtonen V (2003). Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis., 36: 775-780.
13. Boyle Rj, Robins Browne Rm and Tang Ml (2006). Probiotic use in clinical practice: What are the risks? Am. J. Clin. Nutr., 83: 1256-64.
14. Castillo NA, De Moreno De Leblanc A, CMG and Perdigon G (2013). Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. J. Appl. Microbiol., 114: 861-876.
15. Challa A, Rao DR, Chawan CB and Shackelford L (1997). Bifid bacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis, 18: 517-521.
16. Corcoran BM, Stanton C, Fitzgerald GF & Ross RP (2007). Growth of probiotic lactobacilli in the presence of oleic acid enhances subsequent survival in gastric juice. Microbiology, 153: 291-299.
17. Das L, Bhaumik E, Raychaudhuri U and Chakraborty R (2012). Role of nutraceuticals in human health. J. Food Sci. Technol., 49:173-183.
18. DE Moreno DE Leblanc A, Matar C and Perdigon G (2007). The application of probiotics in cancer. Br. J. Nutr., 98(Suppl 1): S105-110.
19. DE Waard R, Garssen J, Bokken GC and Vos JG (2002). Antagonistic activity of lactobacillus casei strain shirota against gastrointestinal listeria monocytogenes infection in rats. Int. J. Food Microbiol., 73: 93-100.
20. Franz C M, Huch M, Abriouel H, Holzapfel W and Galvez A (2011). Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol., 151: 125-140.
21. Ghadimi D, De Vrese M, Heller KJ and Schrezenmeir J (2010). Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagyrestraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen. Int. Immunopharmacol., 10: 694-706.
22. Gibson GR and Roberfroid MB (1995). Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr., 125: 1401-12.
23. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M and Campieri M (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A doubleblind, placebo-controlled trial. Gastroenterology, 119: 305-309.
24. Goldin BR & Gorbach SL (1984). The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr., 5:756-761
25. Gupta P, Andrew H, Kirschner BS and Guandalini S (2000). Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr., 31: 453-457.
26. Hasslof P, Hedberg M, Twetman S and Stecksen-Blicks C (2010). Growth inhibition of oral mutans streptococci and candida by commercial probiotic. BMC Oral Health, 10: 18.
27. Hoesl CE and Altwein JE (2005). The probiotic approach: an alternative treatment option in urology. Eur. Urol., 47: 288-296.
28. Huang SH, He L, Zhou Y, Wu CH and Jong A (2009). Lactobacillus rhamnosus GG suppresses meningitic E. coli K1 penetration across human intestinal epithelial cells in vitro and protects neonatal rats against experimental hematogenous meningitis. Int. J. Microbiol., 647862.
29. Hugo AA, Kakisu E, De Antoni GL & Perez PF (2008). Lactobacilli antagonize biological effects of enterohaemorrhagic escherichia coli in vitro. Lett. Appl. Microbiol., 46: 613-619.
30. Ivory K, Chambers Sj, Pin C, Prieto E, Arques Jl and Nicoletti C (2008). Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin. Exp. Allergy, 38: 1282-1289.
31. Jack RW, Tagg JR and Ray B (1995). Bacteriocins of gram-positive bacteria. Microbiol. Rev., 59: 171-200.
32. JEBUR M (2010). Therapeutic efficacy of Lactobacillus acidophilus against bacterial isolates from burn wounds. N. Am. J. Med. Sci., 2: 586-591.
33. Jureen R, Sondenaa K, Hoiby EA and Digranes A (2002). Lactobacillus rhamnosus septicaemia in a patient with a graft in the inferior. Scand J. Infect Dis., 34: 135-136.
34. Karska-Wysocki B, Bazo M and Smoragiewicz W (2010). Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol. Res., 165: 674-686.
35. Khan SH and Ansari FA (2007). Probiotics the friendly bacteria with market potential in global market. Pak. J. Pharm. Sci., 20: 76-82.
36. Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC and Song IS (2008). The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter, 13: 261-268.
37. Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, Esterman A and Young GP (2005). A symbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogendamaged cells in rat colon. J. Nutr., 135: 996-1001.
38. Lee Y and Salminen S (1995). The coming of age of probiotics. Trends Food Sci. Technol., 6:241-245
39. Lin SY, Ayres JW, Winkler W Jr and Sandine WE (1989). Lactobacillus effects on cholesterol: In vitro and in vivo results. J. Dairy Sci., 72: 2885-2899.
40. Lyons A, O'mahony D, O'brien F, Macsharry J, Sheil B, Ceddia M, Russell W M, Forsythe P, Bienenstock J, Kiely B, Shanahan F and O'mahony L (2010). Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin. Exp. Allergy, 40: 811-819.
41. Mackay AD, Taylor MB, Kibbler CC and Hamilton-Miller JM (1999). Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect., 5: 290-292.
42. Mangiante G, Canepari P, Colucci G, Marinello P, Signoretto C, Nicoli N and Bengmark S (1999). A probiotic as an antagonist of bacterial translocation in experimental. Chir. Ital., 51: 221-226.
43. Marteau P, Pochart P, Bouhnik Y, Zidi S, Goderel I and Rambaud JC (1992). Survival of lactobacillus acidophilus and Bifidobacterium sp. In the small intestine following ingestion in fermented milk. A rational basis for the use of probiotics in man. Gastroenterol. Clin. Biol., 16: 25-28.
44. Marteau P and Seksik P (2004). Tolerance of probiotics and prebiotics. J. Clin. Gastroenterol., 38: S67-69.
45. Mastro TD, Spika JS, Lozano P, Appel J and Facklam RR (1990). Vancomycin-resistant pediococcus acidilactici: Nine cases of bacteremia. J. Infect Dis., 161: 956-960.
46. Matsuzaki T (1998). Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol., 41: 133-140.
47. Michail S and Abernathy F (2002). Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J. Pediatr. Gastroenterol. Nutr., 35: 350-355.
48. Moussavi M and Adams M C (2010). An in vitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations. Curr. Microbiol., 60: 327-335.
49. Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S and Korpela R (2007). Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int. J. Antimicrob. Agents, 29: 66-72.
50. O'riordan K, Andrews D, Buckle K and Conway P (2001). Evaluation of micro encapsulation of a Bifidobacterium strain with starch as an approach to prolonging viability during storage. J. Appl. Microbiol., 91: 1059-1066.
51. Oggioni MR, Pozzi G, Valensin PE, Galieni P and Bigazzi C (1998). Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J. Clin. Microbiol., 36: 325-326.
52. Ohigashi S, Hoshino Y, Ohde S and Onodera H (2011). Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg. Today, 41: 1200-1206.
53. Petzinger E and Ziegler K (2000). Ochratoxin A from a toxicological perspective. J. Vet. Pharmacol. Ther., 23: 91-98.
54. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'riordan M, O'sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B and Collins JK (2007). Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr., 85: 488-496.
55. Rao CV, Sanders ME, Indranie C, Simi B and Reddy BS (1999). Prevention of colonic preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F344 rats. Int. J. Oncol., 14: 939-944.
56. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S and Koskela M (1999). Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect Dis., 28: 1159-1160.
57. Richard V, Van Der Auwera P, Snoeck R, Daneau D and Meunier F (1988). Nosocomial bacteremia caused by Bacillus species. Eur. J. Clin. Microbiol. Infect Dis., 7: 783-785.
58. Rts Resource L (2012). The european market for probiotics and prebiotics. Available: http://www. docstoc.com/docs/99272698/THE EUROPEANMARKET-FOR-PROBIOTICS-AND-PREBIOTICS.
59. Saini R, Saini S and Sharma S (2010). Potential of probiotics in controlling cardiovascular diseases. J. Cardiovasc. Dis. Res., 1: 213-214.
60. Salminen S, Von Wright A, Morelli L, Marteau P, Brassart D, De Vos WM, Fonden R, Saxelin M, Collins K, Mogensen G, Birkeland SE and Mattila-Sandholm T (1998). Demonstration of safety of probiotics a review. Int. J. Food Microbiol., 44: 93-106.
61. Sanders ME (1998). Overview of functional foods: Emphasis on probiotic bacteria. Int. Diar. J., 8: 341-347.
62. Scholz-Ahrens KE, Ade P, Marten B, Weber, P, Timm W, Acil Y, Gluer CC and Schrezenmeir J (2007). Prebiotics, probiotics and synbiotics affect mineral absorption, bone mineral content and bone structure. J. Nutr., 137: 838s-846s.
63. Sendra E, Fayos P, Lario Y, Fernandez-Lopez J, Sayas-Barbera E and Perez-Alvarez JA (2008). Incorporation of citrus fibers in fermented milk containing probiotic bacteria. Food Microbiol., 25: 13-21.
64. Sheil B, Macsharry J, O'callaghan L, O'riordan A, Waters A, Morgan J, Collins JK, O'mahony L and Shanahan F (2006). Role of interleukin (IL-10) in probioticmediated immune modulation: An assessment in wild-type and IL-10 knock-out mice. Clin. Exp. Immunol., 144: 273-280.
65. Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YJ, Yang HB and Wu JJ (2006). Pretreatment with Lactobacillus-and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy. Am. J. Clin. Nutr., 83: 864-869.
66. Shiby VK and Mishra HN (2013). Fermented milks and milk products as functional foods a review. Crit. Rev. Food Sci. Nutr., 53: 482-496.
67. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N and Reddy BS (1997). Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 18: 833-841.
68. Sire JM, Donnio PY, Mesnard R, Pouedras P and Avril JL (1992). Septicemia and hepatic abscess caused by Pediococcus acidilactici. Eur. J. Clin. Microbiol. Infect Dis., 11: 623-625.
69. Skopinska E, Lachowicz D, Wultanska D, Pawlowska J, Jedrzejewska A, Obuch-Woszczatynski P and Pituch H (2012). Assessment of antagonistic activity in vitro Lactobacillus spp. strains againts Clostridum difficile strains isolated from gastrointestinal tract of patients hospitalized in three hospitals in region Mazovia. Med. Dosw. Mikrobiol., 64: 109-114.
70. So JS, Song MK, Kwon HK, Lee CG, Chae CS, Sahoo A, Jash A, Lee SH, Park ZY and Im SH (2011). Lactobacillus casei enhances type II collagen/ glucosamine-mediated suppression of. Life Sci., 88: 358-366.
71. Stanton C, Gardiner G, Meehan H, Collins K, Fitzgerald G, Lynch PB and Ross RP (2001). Market potential for probiotics. Am. J. Clin. Nutr., 73: 476s-483s.
72. Suarez-Quiroz M, Gonzalez-Rios O, Barel M, Guyot B, Schorr-Galindo S and Guiraud JP (2005). Effect of the post-harvest processing procedure on OTA occurrence in artificially contaminated coffee. Int. J. Food Microbiol., 103: 339-345.
73. SUN J, HU XL, LE GW and SHI YH (2010). Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation. Lett. Appl. Microbiol., 50: 264-269.
74. Sykora J, Valeckova K, Amlerova J, Siala K, Dedek P, Watkins S, Varvarovska J, Stozicky F, Pazdiora P and Schwarz J (2005). Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: A prospective randomized double-blind study. J. Clin. Gastroenterol., 39: 692-698.
75. Tannock GW, Munro K, Harmsen HJM, Welling GW, Smart J and Gopal PK (2000). Analysis of the fecal microflora of human subjects consuming a probiotic product containing lactobacillus rhamnosus DR20. Appl. Environ. Microbiol., 66: 2578-2588.
76. Teanpaisan R, Piwat S and Dahlen G (2011). Inhibitory effect of oral Lactobacillus against oral pathogens. Lett. Appl. Microbiol., 53: 452-459.
77. Tsai CC, Lin PP and Hsieh YM (2008). Three lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. Anaerobe, 14: 61-67.
78. Tuomola EM, Ouwehand AC and Salminen SJ (1999). Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics. Lett. Appl. Microbiol., 28: 159-163.
79. Vesa T, Pochart P and Marteau P (2000). Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum. Aliment. Pharmacol. Ther., 14: 823-828.
80. Xie N, Cui Y, Yin YN, Zhao X, Yang JW, Wang, ZG, Fu N, Tang Y, Wang XH, Liu XW, Wang CL & Lu FG (2011). Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a highcholesterol diet. BMC Complement Altern. Med., 11: 53.
81. Xu RY, Wan YP, Fang QY, Lu W and Cai W (2012). Supplementation with probiotics modifies gut flora and attenuates liver fat. J. Clin. Biochem. Nutr., 50: 72-77.
82. Yang J, Huang K, Qin S, Wu X, Zhao Z and Chen F (2009). Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Dig. Dis. Sci., 54: 246-254.
83. Yasutake N, Matsuzaki T, Kimura K, Hashimoto S, Yokokura T and Yoshikai Y (1999). The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice. Med. Microbiol. Immunol., 188: 9-14.
84. Yesilova Y, Calka O, Akdeniz N and Berktas M (2012). Effect of probiotics on the treatment of children with atopic dermatitis. Ann. Dermatol., 24: 189-193.
85. Zabihollahi R, Motevaseli E, Sadat SM, Azizi-Saraji AR, Asaadi-Dalaie S and Modarressi MH (2012). Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Daru, 20: 53.
86. Zhang JW, Du P, Gao J, Yang BR, Fang WJ & Ying CM (2012). Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am. J. Med. Sci., 343: 199-205.
87. Zhang XB and Ohta Y (1993). Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat. Res., 298: 247-253.
88. Zhang Z, Liu C and Guo X (2008). Safety of probiotics a review. Wei. Sheng. Wu. Xue. Bao., 48: 257-261.